Compare Bio Protocol (BIO) vs Xertra (STRAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Xertra — how do they compare? Bio Protocol trades at Rp440.98 (market cap Rp997,34M, Rp163,74M 24h volume), while Xertra trades at Rp146.81 (market cap Rp321,99M, Rp7,47M 24h volume). The key difference: Bio Protocol is far larger — about 3.1× Xertra's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Xertra's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Xertra for 39 Days on average.
| BIO | STRAX | |
|---|---|---|
Market Cap | Rp997,34M | Rp321,99M |
Volume (24h) | Rp163,74M | Rp7,47M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 2,2B STRAX |
Typical Hold Time | 18 Days | 39 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
STRAX is currently trading at Rp147.7, exhibiting a bearish technical trend with mixed signals; moving averages indicate selling pressure while oscillators show some bullish momentum. The asset faces resistance near Rp158 and finds support at Rp139. No recent protocol updates or significant ecosystem developments were noted. Trading volume remains modest with a market cap of Rp322.67M.
Overall outlook is cautious due to bearish technicals and lack of fundamental catalysts. Key opportunities lie in oversold oscillator signals suggesting potential rebounds, but major risks include low liquidity and high volatility. Investors should monitor for any network updates or exchange listings that could impact price action.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Xertra
Stratis is a blockchain-as-a-service platform that offers several products and services for enterprises, including launching private sidechains, running full nodes, developing and deploying smart contracts, an initial coin offering platform, and a proof-of-identity application. The company also provides cryptocurrency wallets and blockchain consulting services.
Read more on STRAX →
